1 February 2024
Metabolites | Highly Cited Papers in 2023 in the Section “Lipid Metabolism”
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
1. “Enhanced Carotid Plaque Echolucency Is Associated with Reduced Cognitive Performance in Elderly Patients with Atherosclerotic Disease Independently on Metabolic Profile”
*Editor’s Choice
by Daniela Mastroiacovo, Alessandro Mengozzi, Francesco Dentali, Fulvio Pomero, Agostino Virdis, Antonio Camerota, Mario Muselli, Stefano Necozione, Raffaella Bocale, Claudio Ferri et al.
Metabolites 2023, 13(4), 478; https://doi.org/10.3390/metabo13040478
Available online: https://www.mdpi.com/2218-1989/13/4/478
2. “A Strategy for Uncovering the Serum Metabolome by Direct-Infusion High-Resolution Mass Spectrometry”
*Editor’s Choice
by Xiaoshan Sun, Zhen Jia, Yuqing Zhang, Xinjie Zhao, Chunxia Zhao, Xin Lu and Guowang Xu
Metabolites 2023, 13(3), 460; https://doi.org/10.3390/metabo13030460
Available online: https://www.mdpi.com/2218-1989/13/3/460
3. “Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity”
by Vanessa D’Antongiovanni, Matteo Fornai, Laura Benvenuti, Clelia Di Salvo, Carolina Pellegrini, Federica Cappelli, Stefano Masi and Luca Antonioli
Metabolites 2023, 13(3), 410; https://doi.org/10.3390/metabo13030410
Available online: https://www.mdpi.com/2218-1989/13/3/410
4. “Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study”
by Alessandro Mengozzi, Nicola Riccardo Pugliese, Giovambattista Desideri, Stefano Masi, Fabio Angeli, Carlo Maria Barbagallo, Michele Bombelli, Federica Cappelli, Edoardo Casiglia, Rosario Cianci et al.
Metabolites 2023, 13(2), 244; https://doi.org/10.3390/metabo13020244
Available online: https://www.mdpi.com/2218-1989/13/2/244
5. “High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity”
by Damien Denimal, Serge Monier, Benjamin Bouillet, Bruno Vergès and Laurence Duvillard
Metabolites 2023, 13(2), 253; https://doi.org/10.3390/metabo13020253
Available online: https://www.mdpi.com/2218-1989/13/2/253
6. “Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target”
*Editor’s Choice
by Allison B. Reiss, Saba Ahmed, Maryann Johnson, Usman Saeedullah and Joshua De Leon
Metabolites 2023, 13(4), 479; https://doi.org/10.3390/metabo13040479
Available online: https://www.mdpi.com/2218-1989/13/4/479
7. “Atherosclerosis Calcification: Focus on Lipoproteins”
by Jaap G. Neels, Georges Leftheriotis and Giulia Chinetti
Metabolites 2023, 13(3), 457; https://doi.org/10.3390/metabo13030457
Available online: https://www.mdpi.com/2218-1989/13/3/457
8. “Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options”
by Bilal Bashir, Jan H. Ho, Paul Downie, Paul Hamilton, Gordon Ferns, Dev Datta, Jaimini Cegla, Anthony S. Wierzbicki, Charlotte Dawson, Fiona Jenkinson et al.
Metabolites 2023, 13(5), 621; https://doi.org/10.3390/metabo13050621
Available online: https://www.mdpi.com/2218-1989/13/5/621